State AGs To Expand Price-Fixing Case To Go After Big Pharma Players For Generic Drug Costs
The complaint alleges an industry-wide conspiracy divide up the market as a way to drive up prices.
U.S. States Allege Broad Generic Drug Price-Fixing Collusion
Forty-six U.S. state attorneys general will seek to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG's generic unit Sandoz and India-based Sun Pharmaceutical Industries, people familiar with the matter said. The original complaint, being litigated in federal court in Pennsylvania, describes an industry-wide conspiracy in which companies divide up the market as a way to push up prices. (10/31)
Mylan's President Targeted In Generic Drug Pricing Probe
Mylan NV’s second-ranking executive was named in a civil investigation by dozens of states conducting a multiyear probe into alleged price collusion by makers of generic drugs that is now targeting senior managers. State attorneys general said they’re seeking to sue Rajiv Malik, Mylan’s president and executive director, as part of an expanded complaint against pharmaceutical companies from 45 states and the District of Columbia, according to a statement by Connecticut Attorney General George Jepsen. (Chen and McLaughlin, 10/31)